LEN vs MLAB · rev $34.19B vs P/E 81, rev $241.0M
LEN (LEN) versus Mesa Laboratories Inc (MLAB) — a side-by-side from cached financials, not a winner call.
LEN (LEN) common stock.
Mesa Laboratories Inc (MLAB) is a scientific & technical instruments company listed on US.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
Latest reported MLAB revenue for 2025-03-31 was $241.0M. Net income was -$2.0M. Revenue was up 11.5% from 2024-03-31 to 2025-03-31. MLAB currently screens at market cap $538.3M and trailing P/E 80.5.
LEN currently screens at market cap $0. MLAB currently screens at market cap $538.3M and trailing P/E 80.5.
Not investment advice. Open the LEN and MLAB stock pages for the full models.
Not investment advice.